.jpg?format=webp&quality=80&width=3840)
A study found that respiratory motion-managed radiotherapy (RT) can reduce side effects and improve outcomes in non-small cell lung cancer (NSCLC) patients. The study involved 31 patients treated with RT using the 4D-CT-based volumetric arc therapy technique. They found that PTV did not increase, the target was covered with 95% accuracy, and all risky organ doses were significantly lower. Two-year survival of 26% was achieved without serious side effects.
Like
Save
Share